More than 150 clinical trials are open at Providence Cancer Institute
Providence Cancer Institute is currently conducting more than 150 research studies, including clinical trials of targeted therapies and novel immunotherapy approaches. Please see the links below for studies in specific disease areas.
20 clinical trials open to lung cancer patients
At Providence Cancer Institute, 20 open studies offer access to promising new therapies for patients with lung cancer. Two of the newest studies are using combined therapies, including immunotherapies, to potentially improve results for patients with advanced non-small cell lung cancer: